Clinical significance of TP53 mutation in myeloma.
Chng
W J
WJ
Price-Troska
T
T
Gonzalez-Paz
N
N
Van Wier
S
S
Jacobus
S
S
Blood
E
E
Henderson
K
K
Oken
M
M
Van Ness
B
B
Greipp
P
P
Rajkumar
S V
SV
Fonseca
R
R
D014408:Biomarkers, Tumor / Q000097:blood*; D002886:Chromosomes, Human, Pair 17 / Q000235:genetics; D018389:Codon, Nonsense; D015331:Cohort Studies; D004252:DNA Mutational Analysis; D018450:Disease Progression; D005500:Follow-Up Studies; D016158:Genes, p53; D006801:Humans; D053208:Kaplan-Meier Estimate; D009101:Multiple Myeloma / Q000235:genetics* / Q000401:mortality; D050505:Mutant Proteins / Q000097:blood*; D011379:Prognosis; D016016:Proportional Hazards Models; D017384:Sequence Deletion; D016159:Tumor Suppressor Protein p53 / Q000097:blood*
D014408:Biomarkers, Tumor; D018389:Codon, Nonsense; D050505:Mutant Proteins; D016159:Tumor Suppressor Protein p53